Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000049226 | SCV000077240 | benign | RASopathy | 2012-01-09 | criteria provided, single submitter | clinical testing | The variant is found in NOONAN panel(s). |
Prevention |
RCV000246549 | SCV000310867 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000246549 | SCV001362305 | benign | not specified | 2019-08-12 | criteria provided, single submitter | clinical testing | Variant summary: CBL c.1095+19G>T alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.59 in 250970 control chromosomes, suggesting that it is the major allele and therefore benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. |
Invitae | RCV000049226 | SCV001729052 | benign | RASopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000610899 | SCV001776147 | benign | CBL-related disorder | 2021-07-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000509552 | SCV002048590 | benign | not provided | 2023-11-16 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315579 | SCV004016965 | benign | Juvenile myelomonocytic leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000509552 | SCV000607339 | not provided | not provided | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Diagnostic Laboratory, |
RCV000610899 | SCV000733007 | benign | CBL-related disorder | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000246549 | SCV001925669 | benign | not specified | no assertion criteria provided | clinical testing |